A post-trial assessment of factors influencing study drug adherence in a randomized biomedical HIV-1 prevention trial

AIDS and Behavior

Volumn 15, Issue 5, 2011, Pages 897-904

  Jacob, Shevin T ^a,d   Baeten, Jared M ^a,b   Hughes, James P ^a   Peinado, Jesús ^c   Wang, Jing ^d   Sanchez, Jorge ^c   Reid, Stewart E ^e,f   Delany Moretlwe, Sinead ^g   Cowan, Frances ^h,i   Fuchs, Jonathan D ^j   Koblin, Beryl ^k   Griffith, Sam ^l   Wald, Anna ^a,d   Celum, Connie ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c ASOCIACIÓN CIVIL IMPACTA SALUD Y EDUCACIÓN   (Peru)

^d Fred Hutchinson Cancer Research Center   (United States)

^e and Clinical Center   (United States)

^f CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^g UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^j SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^k NEW YORK BLOOD CENTER   (United States)

^l FAMILY HEALTH INTERNATIONAL   (United States)

more..

Author keywords

Adherence; Biomedical prevention; Clinical trials; HIV 1

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; DRUG EFFECT; EVALUATION; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEDICAL RESEARCH; MIDDLE AGED; PATIENT COMPLIANCE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEXUAL BEHAVIOR; SOCIOECONOMICS; STATISTICS;

ACYCLOVIR; ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; BIOMEDICAL RESEARCH; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEXUAL BEHAVIOR; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 80052055283     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-010-9853-2     Document Type: Article

References (10)

1. 2008 Report on the global AIDS epidemic. "Status of the global HIV epidemic." Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS), 2008. Available at: http://www.unaids.org/en/KnowledgeCentre/HIVData/ GlobalReport/2008/2008-Global-report.asp.
2. Padian NS, van der Straten A, Ramjee G, et al. Diaphragm and lubricant gel of prevention of HIV acquisition in southern African women: a randomized controlled trial. Lancet. 2007;13:251-61. (Pubitemid 47069513)
3. Watson-Jones D, Weiss HA, Rusizoka M, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med. 2008;368:1560-71. (Pubitemid 351519816)
4. Skoler-Karpoff S, Ramjee G, Ahmed K, et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: A randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9654):1977-87.
5. Chesney MA. The elusive gold standard: future perspectives for HIV adherence assessment and intervention. J Acquir Immune Defic Syndr. 2006;43(S1):S149-55. (Pubitemid 44885655)
6. Lagakos SW, Gable AR, editors. Design considerations: adherence. In: Methodological challenges in biomedical HIV prevention trials. Washington, DC: National Academies Press; 2008. p. 5.1-5.24.
7. Celum C, Wald A, Hughes J, et al. Effect of acyclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomized, double-blind, placebo- controlled trial. Lancet. 2008;371:2109-19. (Pubitemid 351902179)
8. Gupta R, Wald A, Krantz E, et al. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. J Infect Dis. 2004;190:1374-81. (Pubitemid 39332176)
9. Weiss HA, Wasserheit JN, Barnabas RV, Hayes RJ, Abu-Raddad LJ. Persisting with prevention: the importance of adherence for HIV prevention. Emerg Themes Epidemiol. 2008;5(8):1-7.
10. Plummer ML, Watson-Jones D, Lees S, et al. A qualitative study of participant adherence in a randomized controlled trial of herpes suppressive therapy for HIV prevention in Tanzania. AIDS Care. 2010;22(4):499-508.